Where Will Jasper Therapeutics Inc (JSPR) Stock Go Next After It Has Gained 18.79% in a Week?

The market has been high on Jasper Therapeutics Inc (JSPR) stock recently. JSPR gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Jasper Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on JSPR!

See Full JSPR Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With JSPR Stock Today?

Jasper Therapeutics Inc (JSPR) stock is trading at $1.77 as of 2:31 PM on Thursday, May 18, a gain of $0.11, or 6.33% from the previous closing price of $1.66. The stock has traded between $1.63 and $1.81 so far today. Volume today is high. So far 895,885 shares have traded compared to average volume of 669,325 shares.

More About Jasper Therapeutics Inc

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Click Here to get the full Stock Report for Jasper Therapeutics Inc stock.